Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ImmunoGen, Inc. | SVP & CHIEF COMMERCIAL OFFICER | Restricted Stock Unit | 0 | $0 | $29.30 | Feb 12, 2024 | Direct |
ImmunoGen, Inc. | SVP & CHIEF COMMERCIAL OFFICER | Stock Option (Right to Buy) | 0 | $0 | $4.56 | Feb 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IMGN | ImmunoGen, Inc. | Feb 12, 2024 | 3 | $0 | 4 | Feb 12, 2024 | SVP & CHIEF COMMERCIAL OFFICER |
IMGN | ImmunoGen, Inc. | Feb 1, 2024 | 1 | $0 | 4 | Feb 5, 2024 | SVP & CHIEF COMMERCIAL OFFICER |
IMGN | ImmunoGen, Inc. | Apr 28, 2023 | 2 | $0 | 4 | May 2, 2023 | SVP & CHIEF COMMERCIAL OFFICER |
IMGN | ImmunoGen, Inc. | Apr 24, 2023 | 0 | $0 | 3 | May 2, 2023 | SVP & CHIEF COMMERCIAL OFFICER |